SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-17-005292
Filing Date
2017-11-06
Accepted
2017-11-06 06:05:31
Documents
4
Period of Report
2017-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT txmd-8k_110617.htm 8-K 20278
2 PRESS RELEASE - THERAPEUTICSMD ANNOUNCES THIRD QUARTER 2017 FINANCIAL RESULTS ex99-1.htm EX-99.1 80669
3 PRESS RELEASE - THERAPEUTICSMD ANNOUNCES PLAN TO RESUBMIT THE NEW DRUG APPLICATI ex99-2.htm EX-99.2 11342
4 GRAPHIC image_001.jpg GRAPHIC 3285
  Complete submission text file 0001387131-17-005292.txt   118427
Mailing Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487
Business Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 171178129
SIC: 2834 Pharmaceutical Preparations